Blasco Maria A, Hahn William C
Department of Immunology and Oncology, National Centre of Biotechnology, Spanish Council for Scientific Research (CSIC), Campus de Cantoblanco, Madrid E-28049, Spain.
Trends Cell Biol. 2003 Jun;13(6):289-94. doi: 10.1016/s0962-8924(03)00085-0.
The maintenance of telomeres, nucleoprotein structures that constitute the ends of eukaryotic chromosomes, regulates many crucial cellular functions and might, in multicellular organisms, participate in the control of complex phenotypes such as aging and cancer. Stabilization of telomere length is strongly associated with cellular immortalization, and constitutive telomerase activation occurs in most human cancers. Such observations form the basis for the prevailing model that postulates that alterations in telomere biology both suppress and facilitate malignant transformation by regulating genomic stability and cell life span. However, recent findings suggest that telomere maintenance might not be an obligate requirement for initial tumor formation in some settings and that telomerase activation contributes to tumorigenesis independently of its role in maintaining telomere length. These recent developments indicate that our understanding of telomere biology remains incomplete and implicate additional complexity in the relationships among telomeres, telomerase and cancer.
端粒是构成真核染色体末端的核蛋白结构,其维持调控着许多关键的细胞功能,在多细胞生物中可能参与对诸如衰老和癌症等复杂表型的控制。端粒长度的稳定与细胞永生化密切相关,在大多数人类癌症中都存在组成型端粒酶激活。这些观察结果构成了当前模型的基础,该模型假定端粒生物学的改变通过调节基因组稳定性和细胞寿命来抑制和促进恶性转化。然而,最近的研究结果表明,在某些情况下,端粒维持可能不是初始肿瘤形成的必要条件,并且端粒酶激活对肿瘤发生的作用与其在维持端粒长度方面的作用无关。这些最新进展表明,我们对端粒生物学的理解仍然不完整,并且暗示了端粒、端粒酶和癌症之间关系存在更多的复杂性。